Related Experiment Video
Updated: Dec 29, 2025

10:07
Exploring Protein-Glycan Interactions: Advances in Nuclear Magnetic Resonance
Published on: August 26, 2025
467
Underappreciated Chemical Interactions in Protein-Ligand Complexes
1Evotec (UK) Ltd., Oxfordshire, UK. andrew.anighoro@evotec.com.
Methods in Molecular Biology (Clifton, N.J.)
|February 5, 2020
Summary
Medicinal chemistry often overlooks crucial non-covalent interactions in drug design. Exploring these underappreciated forces can significantly enhance drug potency and guide structure-based drug design strategies.
Area of Science:
- * Medicinal Chemistry and Computational Drug Design
Background:
- * Non-covalent interactions are fundamental to molecular recognition and drug-target binding.
- * Traditional focus in medicinal chemistry is on hydrophobic contacts, hydrogen bonds, salt bridges, and aromatic stacking interactions.
- * Underappreciated non-covalent interactions significantly stabilize protein-ligand complexes, impacting drug efficacy.
Purpose of the Study:
- * To highlight selected underappreciated non-covalent interactions in protein-ligand complexes.
- * To discuss the impact of these interactions on drug design strategies.
- * To provide examples of how understanding these interactions can improve lead compound potency.
Main Methods:
- * Review of scientific literature on protein-ligand interactions.
- * Analysis of computational studies on non-covalent interactions.
- * Case studies illustrating the role of specific non-covalent interactions in drug design.
Main Results:
- * Identification of various non-covalent interactions beyond the commonly studied ones.
- * Demonstration of the significant contribution of these interactions to binding affinity and stability.
- * Examples showing how targeting these interactions can lead to improved drug candidates.
Conclusions:
- * A broader consideration of non-covalent interactions is essential for effective drug design.
- * Computational analysis of diverse non-covalent interactions aids in understanding structure-activity relationships (SAR).
- * Recognizing and leveraging underappreciated interactions can optimize drug potency and guide future medicinal chemistry efforts.
Related Concept Videos
Ligand Binding Sites
14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
Ligand Binding Sites
8.5K
8.5K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
The Equilibrium Binding Constant and Binding Strength
14.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.7K
The Equilibrium Binding Constant and Binding Strength
9.8K
9.8K
Complexation Equilibria: The Chelate Effect
1.1K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.1K

